The therapeutic efficacy of Chinese patent medicine combined with routine western medicine in the treatment of coronavirus disease 2019 (COVID-19): A protocol for systematic review and meta-analysis

BACKGROUND: Coronavirus disease 2019 (COVID-19) is a potentially fatal disease. clinical practice shows that Chinese Patent Medicine (CPM) has played an important role in the outbreak, Among them, Jinhua Qinggan granules, Lianhua Qingwen capsule, and Xuebiqing injection have an effect in treating CO...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jingxia, Li, Shasha, Zhao, Chongbo, Wang, Weifeng, Li, Fan, Li, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
3800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505289/
https://www.ncbi.nlm.nih.gov/pubmed/32957380
http://dx.doi.org/10.1097/MD.0000000000022277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505289/
https://www.ncbi.nlm.nih.gov/pubmed/32957380
http://dx.doi.org/10.1097/MD.0000000000022277

Ejemplares similares